CVE-2026-4413: IBM Concert · Cross-site Scripting
Affects IBM ConcertSource CVE Database V5
Not known to be exploited · CVSS 6.1 Medium.
Data as of 26 Oct 2026, 17:30 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 11% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 19 Oct 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| IBMConcert | Affected
| Fixed in– |
Mavencom.ibm/concertpkg:maven/com.ibm/concertOther threats | Affected
| Fixed in– |
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
Until a fix is available, consider restricting access to the affected versions and applying web application firewall rules to detect and block XSS payloads if feasible.
Description
IBM Concert 1.0 through 3.0.0 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.